Recent news on Palifermin

Amgen Names David Lacey, MD, Senior Vice President, Head of Research  -  May 23, 2007
PharmaLive.com (press release),...which ultimately was approved as Kepivance(R) (palifermin), the first and only growth factor indicated to decrease the incidence and duration of severe

Intensity-modulated Radiotherapy Improves QOL Measurements in Head ...  -  26 Apr 2007
Cancer Consultants (press release),Kepivance® (palifermin, keratinocyte growth factor) decreases mucositis associated with total body irradiation but has not been evaluated in head and neck

Kepivance® May Decrease Oral Mucositis Following High-dose ...  -  Jan 10, 2007
Cancer Consultants (press release),Several studies presented at the 2006 meeting of the American society of Hematology in December suggest that Kepivance® (palifermin) decreases the frequency

Kepivance® May Decrease Oral Mucositis Following High-Dose ...  -  Jan 8, 2007
Cancer Consultants (press release),Prior to the approval of Kepivance (palifermin, keratinocyte growth factor) there were no FDA-approved systemic drugs for the treatment or prevention of

The Effects Of Palifermin In Patients With Impaired Kidney ...  -  Dec 14, 2006
Medical News Today (press release),Palifermin (Kepivance) is approved for use to decrease the chances of developing severe mucositis or injury to the cells lining the mouth,

Kepivance® Decreases Oral Mucositis in Patients with Metastatic ...  -  Nov 27, 2006
Cancer Consultants (press release),The results of a randomized multicenter trial demonstate that Kepivance (palifermin, keritinocyte growth factory) given before chemotherapy reduces the

Kepivance® Reduces Mucositis After Allogeneic Stem Cell ...  09 Nov 2006
Researchers from the University of Minnesota and Michigan have reported that the administration of Kepivance (palifermin, keritinocyte growth factor) before ... -Cancer Consultants (press release), Kepivance® Reduces Mucositis in Colorectal Cancer Patients ...  09 Nov 2006
According to an early online publication in the Journal of Clinical Oncology, Kepivance® (palifermin) can significantly reduce oral mucositis among patients ... -Cancer Consultants (press release), Kepivance® Reduces Mucositis After Allogeneic Stem Cell ...  Nov 2, 2006
According to an article recently published in the journal Blood, Kepivance® (palifermin, keritinocyte growth factor), given before and after allogeneic stem ... -Cancer Consultants (press release), Daily Low Power Laser Therapy May Prevent Oral Mucositis in Stem ...  Oct 25, 2006
At the present time, the main FDA approved treatment for prevention of oral mucositis after autologous stem cell transplantation is Kepivance® (palifermin). ... -Cancer Consultants (press release), Study in the Journal of Clinical Pharmacology  -  Dec 7, 2006
EurekAlert (press release),Palifermin (Kepivance) is approved for use to decrease the chances of developing severe mucositis or injury to the cells lining the mouth,

Kepivance® Decreases Oral Mucositis in Patients with Metastatic ...  -  Nov 27, 2006
Cancer Consultants (press release),The results of a randomized multicenter trial demonstate that Kepivance (palifermin, keritinocyte growth factory) given before chemotherapy reduces the

Palifermin Helps Reduce Incidence of Oral Mucositis in Patients ...  Jun 27, 2006
TORONTO, CANADA -- June 27, 2006 -- Palifermin reduces the incidence of oral mucositis than does standard therapy in patients undergoing haematopoietic stem ... -DG News



Kepivance™ Improves Patient-Assessed Oral Mucositis Following ...  Apr 21, 2006
The results of patient evaluations of a phase III randomized trial of Kepivance™ (palifermin, epidermal growth factor) for the prevention of oral mucositis ... - Cancer Consultants



Amgen's Fourth Quarter 2005 Adjusted Earnings Per Share Increased ...  Jan 26, 2006
Kepivance (palifermin): The Company announced that Kepivance received regulatory approval in the European Union to decrease the incidence, duration and ... - Biotech Intelligence

Wendy's best chance  Jan 22, 2006
Three days before she started radiation she took infusions of palifermin, a drug that protects against mucositis, a side effect of radiation that alters the ... - Bellingham Herald

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional